Versant Capital Management’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $15.9K | Buy |
1,695
+854
| +102% | +$8.01K | ﹤0.01% | 1651 |
|
|
2025
Q1 | $5.98K | Buy |
841
+691
| +461% | +$4.91K | ﹤0.01% | 1966 |
|
|
2024
Q4 | $1.75K | Buy |
+150
| New | +$1.75K | ﹤0.01% | 2084 |
|
|
2024
Q3 | – | Sell |
-85
| Closed | -$1.9K | – | 2061 |
|
|
2024
Q2 | $1.9K | Buy |
85
+68
| +400% | +$1.52K | ﹤0.01% | 1521 |
|
|
2024
Q1 | $468 | Sell |
17
-10
| -37% | -$275 | ﹤0.01% | 1710 |
|
|
2023
Q4 | $823 | Buy |
+27
| New | +$823 | ﹤0.01% | 1566 |
|
|
2023
Q3 | – | Sell |
-20
| Closed | -$816 | – | 2016 |
|
|
2023
Q2 | $816 | Buy |
+20
| New | +$816 | ﹤0.01% | 1670 |
|